CN102256602A - 用于治疗上皮组织的组合物 - Google Patents

用于治疗上皮组织的组合物 Download PDF

Info

Publication number
CN102256602A
CN102256602A CN2009801527052A CN200980152705A CN102256602A CN 102256602 A CN102256602 A CN 102256602A CN 2009801527052 A CN2009801527052 A CN 2009801527052A CN 200980152705 A CN200980152705 A CN 200980152705A CN 102256602 A CN102256602 A CN 102256602A
Authority
CN
China
Prior art keywords
pharmaceutical composition
topiramate
skin
scar
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801527052A
Other languages
English (en)
Chinese (zh)
Inventor
N·A·沙皮拉
A·巴齐莱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novodermix International Ltd
Original Assignee
Novodermix International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novodermix International Ltd filed Critical Novodermix International Ltd
Publication of CN102256602A publication Critical patent/CN102256602A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN2009801527052A 2008-10-21 2009-10-21 用于治疗上皮组织的组合物 Pending CN102256602A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13699408P 2008-10-21 2008-10-21
US61/136994 2008-10-21
PCT/IB2009/054646 WO2010046861A1 (en) 2008-10-21 2009-10-21 Composition for treatment of epithelial tissue

Publications (1)

Publication Number Publication Date
CN102256602A true CN102256602A (zh) 2011-11-23

Family

ID=42118987

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801527052A Pending CN102256602A (zh) 2008-10-21 2009-10-21 用于治疗上皮组织的组合物

Country Status (9)

Country Link
US (1) US20110257257A1 (cg-RX-API-DMAC7.html)
EP (1) EP2361083A4 (cg-RX-API-DMAC7.html)
JP (1) JP2012506417A (cg-RX-API-DMAC7.html)
KR (1) KR20110074611A (cg-RX-API-DMAC7.html)
CN (1) CN102256602A (cg-RX-API-DMAC7.html)
BR (1) BRPI0914454A2 (cg-RX-API-DMAC7.html)
CA (1) CA2741028A1 (cg-RX-API-DMAC7.html)
RU (1) RU2011120054A (cg-RX-API-DMAC7.html)
WO (1) WO2010046861A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104603616A (zh) * 2012-09-07 2015-05-06 株式会社资生堂 使用纤蛋白-3和/或肌聚糖γ作为指标评价脂肪团的方法和评价脂肪团有效药物的方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9468599B2 (en) * 2011-12-27 2016-10-18 Cmpd Licensing, Llc Composition and method for compounded therapy
US9962391B2 (en) 2011-12-27 2018-05-08 Cmpd Licensing, Llc Composition and method for compounded therapy
US11213501B2 (en) 2011-12-27 2022-01-04 Cmpd Licensing, Llc Composition and method for compounded therapy
US10813897B2 (en) 2011-12-27 2020-10-27 Cmpd Licensing, Llc Composition and method for compounded therapy
US11213500B2 (en) 2011-12-27 2022-01-04 Cmpd Licensing, Llc Composition and method for compounded therapy
CA2901973C (en) 2013-02-26 2019-03-12 Asahi Kasei Construction Materials Corporation Phenolic resin foam board, and method for manufacturing same
US20240180946A1 (en) * 2021-03-24 2024-06-06 Orgenesis Inc. Compositions comprising topiramate for treating dermatological conditions
CN115245470A (zh) * 2021-04-27 2022-10-28 山东本真化妆品有限公司 水包油乳液及其在对抗婴儿湿疹中的用途

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097038A1 (en) * 2002-05-14 2003-11-27 Ralph Ryback Method for treating dermatoses and tissue damage
CN1646538A (zh) * 2002-02-15 2005-07-27 奥索-麦克尼尔药品公司 托吡酯盐及其组合物、制备方法和应用
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784692A (en) * 1967-06-16 1974-01-08 Warner Lambert Co 17-propionate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
US4323694A (en) * 1981-04-13 1982-04-06 Finetex, Inc. Benzoic acid esters
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
IL137559A (en) * 2000-07-27 2006-12-31 Amnon Sintov A system for administering drugs through the skin
US20020082222A1 (en) * 2000-11-30 2002-06-27 Shapira Nathan Andrew Treatments for neurogenetic disorders, impulse control disorder, and wound healing
FR2829693B1 (fr) * 2001-09-20 2004-02-27 Oreal Creme cosmetique moussante
US6824786B2 (en) * 2001-11-27 2004-11-30 Ruey J. Yu Compositions comprising phenyl-glycine derivatives
CA2502986C (en) * 2002-10-25 2011-08-23 Foamix Ltd. Cosmetic and pharmaceutical foam
ES2366273T3 (es) * 2003-03-21 2011-10-18 Nexmed Holdings, Inc. Esmalte de uñas antifúngico y procedimiento de utilización.
US6949518B1 (en) * 2003-06-25 2005-09-27 Pao-Hsien Chu Methods for treating macular degeneration with topiramate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1646538A (zh) * 2002-02-15 2005-07-27 奥索-麦克尼尔药品公司 托吡酯盐及其组合物、制备方法和应用
WO2003097038A1 (en) * 2002-05-14 2003-11-27 Ralph Ryback Method for treating dermatoses and tissue damage
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104603616A (zh) * 2012-09-07 2015-05-06 株式会社资生堂 使用纤蛋白-3和/或肌聚糖γ作为指标评价脂肪团的方法和评价脂肪团有效药物的方法

Also Published As

Publication number Publication date
BRPI0914454A2 (pt) 2015-10-27
EP2361083A4 (en) 2013-11-20
RU2011120054A (ru) 2012-11-27
JP2012506417A (ja) 2012-03-15
EP2361083A1 (en) 2011-08-31
CA2741028A1 (en) 2010-04-29
WO2010046861A1 (en) 2010-04-29
KR20110074611A (ko) 2011-06-30
US20110257257A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
CN102256602A (zh) 用于治疗上皮组织的组合物
JP6966455B2 (ja) 侵襲的且つ非侵襲的な処置上のスキンケアのための組成物及び方法
AU2016222802B2 (en) Reduction of adipose tissue
CA3153934C (en) Treatment of skin conditions using high krafft temperature anionic surfactants
CN1188119C (zh) 用于减少眼睛下部黑眼圈出现的方法
JP7421558B2 (ja) 組織修復に適用されるピルフェニドンを含有する半固体油性医薬組成物
TW201210601A (en) Compounds and methods for skin repair
CN102421428B (zh) 用于防止脱发或促进毛发生长的组合物
CN104800150A (zh) 一种米诺地尔乳膏剂及制备方法
US20150283080A1 (en) Stabilized dermatological delivery system for active ingredient compositions for topical administration to the skin
US20030095991A1 (en) Treatment for skin
JP2024542045A (ja) 汎ｂｅｔ阻害剤の使用
US20060127429A1 (en) Topical numbing composition for laser therapy
CN102105142A (zh) 用于治疗红斑狼疮的包括壳聚糖和二羧酸的组合物
US20150306221A1 (en) Mixture of Betamethasone and Tranilast with a Transdermal Gel for Scar Treatment
US20140315991A1 (en) Composition for treatment of epithelial tissue
CN101132804A (zh) 治疗皮肤情况，失调或疾病的胚胎皮肤细胞蛋白组合物及其制备和使用方法
KR20160117529A (ko) 헤파린의 국소 제제
WO2014190182A1 (en) Topical scar treatment composition and method of using same
JP3658114B2 (ja) 皮膚外用剤
CN105193677A (zh) 一种具有祛痘功效的组合物
WO2022131079A1 (ja) 外用組成物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20111123